Paragon Care Limited · ASX:PGC
Paragon Care — Shareholder Meeting (November 2026)
25 slides from Paragon Care's shareholder meeting presentation, Nov 18, 2026
Slide 1: 2026 Annual General Meeting – Chair Address & Presentation
18 November 2026 For personal use only ASX ANNOUNCEMENT 2026 ANNUAL GENERAL MEETING – CHAIR ADDRESS & PRESENTATION Paragon Care Limited (ASX: PGC) (“ParagonCare” or the “Company”) attaches in accordance with ASX Listing Rule 3.13.3, the address to be delivered by Chair, Peter Lacaze and slides to be
Slide 2: Chair's Address
For personal use only CHAIR’S ADDRESS Good afternoon, The 2026 financial year was a period of significant achievement and continued transformation for ParagonCare. Our 3-2-1 integration strategy; 3 businesses, 2 years, 1 team was completed. Guidance targets for sales, EBITDA and Net Debt were al
Slide 3: Annual General Meeting 18th November 2026
rsonal use only Annual General Meeting 18th November 2026 • ParagonCare Limited - ASX PGC AGM 18th November 2026
Slide 4: Disclaimer
Disclaimer Summary information rsonal use only This Presentation contains summary information about ParagonCare, and its activities current as at 18th November 2026. The information in the Presentation is of a general nature and does not purport to be complete or comprise all information which a sha
Slide 5: Presenters
rsonal use only Peter Lacaze Carmen Riley Chairman Chief Executive Officer Presenters AGM 18th November 2026
Slide 6: Welcome & Chair's Address
rsonal use only Peter Lacaze Chairman Welcome & Chairs Address AGM 18th November 2026
Slide 7: Acknowledgement of Country and Traditional Owners
Acknowledgement of Country and Traditional Owners rsonal use only ParagonCare acknowledges the Traditional Owners of the country in which our headquarters are located, in Australia. We recognise the continuing connection to lands, waters and communities and pay our respects to Aboriginal and Torres
Slide 8: Governance: The board that guides us
Governance Experience you can count on The board that guides us. rsonal use only Carmen Riley David Collins Peter Lacaze John Walstab Peter Egglestone CEO & Managing Executive Director, Chairman Non - Executive Director Non - Executive Director Director CFO Peter Lacaze is the Chairman and 28.55% Jo
Slide 9: Format of Meeting
Format of Meeting rsonal use only 1 2 3 4 5 Chair Address Questions and Voting Formal Business CEO Presentation General Questions Procedure AGM 18th November 2026
Slide 10: Question & Voting Procedure
rsonal use only Question & Voting Procedure Annual General Meeting 2026 AGM 18th November 2026
Slide 11: Formal Business
rsonal use only Formal Business Annual General Meeting 2026 AGM 18th November 2026
Slide 12: Receipt and consideration of financial statements & reports
Agenda Item 1 rsonal use only Receipt and consideration of financial statements & reports To receive and consider the financial report of the Company and the related reports of the Directors. (Including the Remuneration Report) and auditors for the financial year ended 30 June 2026. Further informat
Slide 13: Adoption of Remuneration Report
Resolution 1 rsonal use only Adoption of Remuneration Report To consider and, if thought fit, pass the following resolution as an ORDINARY resolution: “That for the purpose of section 250R(2) of the Corporations Act and for all other purposes, the Remuneration Report (included in the Directors' Repo
Slide 14: Re-election of Mr David Collins as a Director
Resolution 2 rsonal use only Re-election of Mr David Collins as a Director To consider, and if thought fit, pass the following resolution as an ordinary resolution: ‘That Mr David Collins, being a Director who retires by rotation pursuant to the Company’s Constitution and being eligible for re-elect
Slide 15: Appointment of Auditor
Resolution 3 rsonal use only Appointment of Auditor To consider, and if thought fit, pass the following resolution as an ordinary resolution: “That, for the purposes of section 327B of the Corporations Act and for all other purposes KPMG having consented in writing to act in the capacity of auditor
Slide 16: Poll & Close of Formal Business
rsonal use only Poll & Close of Formal Business Annual General Meeting 2026 AGM 18th November 2026
Slide 17: CEO Presentation
rsonal use only Carmen Riley Chief Executive Officer CEO Presentation AGM 18th November 2026
Slide 18: FY26 Financial Performance - Strategic Transformation
FY26 Financial Performance - Strategic Transformation Completion of 3-2-1 Strategy $3.7 $26.0 $97.2 $23.7 rsonal use only billion million million million 2.5x Revenue Underlying NPAT1 Underlying EBITDA1 Cash balance Underlying Net Debt2 Up +1.8% on pcp Down (13.6%) on pcp Up +2.1% on pcp Up +16.5% o
Slide 19: Acquisitions Overview
Acquisitions Overview Completed acquisitions contribute to FY26 growth in line with Asia expansion strategy Haju Medical – acquired April 2026 AHP – acquired July 2025 Haju supplies a wide range of leading aesthetics brands in Indonesia and distributes a range of over 40 key products from 20 key bra
Slide 20: Strategy and Outlook
rsonal use only Strategy and Outlook Annual General Meeting 2026 AGM 18th November 2026
Slide 21: FY27 Outlook
FY27 Outlook One partner for the whole of healthcare Geographic & market expansion rsonal use only • Continue to grow our Asia regional presence • Leverage capability and market opportunities in acquired businesses • Expand aesthetics business in Australia and Asian territories • Strategic M&A oppor
Slide 22: Q1 ParagonCare quarterly revenue
Q1 ParagonCare PGC Quarterly Revenue ('000) 1,000,000 ANZ Asia Revenue Q1-FY27 ANZ Asia Margin Q1-FY27 rsonal use only 950,000 59,990 6% 57,992 26% 900,000 850,000 26,189 74% 94% 800,000 ANZ Asia ANZ Asia 750,000 908,339 906,100 917,486 700,000 Business Unit Revenue Q1-FY27 Business Unit Margin Q1-F
Slide 23: Brisbane Site Tour
rsonal use only Brisbane Site Tour Annual General Meeting 2026 AGM 18th November 2026
Slide 24: Q&A
rsonal use only Q&A Annual General Meeting 2026 AGM 18th November 2026
Slide 25: Thank you
rsonal use only Thank you AGM 18th November 2026 23